摘要
目的:探究α-干扰素治疗丙肝的临床效果。方法:收治丙肝患者78例,按照年龄阶段的不同进行分组,给予α-干扰素进行治疗,对比、分析临床疗效的异同。结果:对比4个不同年龄的总有效率,24~34岁总有效率94.1%,35~44岁84.6%,45~55岁30.7%,55岁以上22.7%,年龄越大,应用α-干扰素治疗丙肝患者的临床疗效越低,组间进行比较,差异有统计学意义(P<0.05)。病理分期越重,临床有效率越差。结论:患者的年龄大小、病理分期的轻重都会影响α-干扰素治疗丙肝的临床效果,及时、尽早地在明确丙肝诊断后积极应用治疗α-干扰素,对临床有效率及预后具有重要意义。
Objective:To investigate the clinical effects of α-interferon in the treatment of patients with hepatitis C.Methods:78 patients with hepatitis C were selected.All patients were grouped according to different age.They were all treated byα-interferon.We compared and analyzed the similarities and differences of clinical efficacy.Results:We compared the total effective rate of 4 different ages;the total effective rate of 24~34 years old was 94.1%;35~44 years old was 84.6%;45~55 years old was 30.7%;over 55 years old was 22.7% ;the elder the age,the lower the curative effect of α-interferon in the treatment of patients with hepatitis C,comparison between groups,and the differences were statistically significant(P<0.05).The more severer of pathological stage,the worse of clinical efficiency.Conclusion:The severity of age and pathological staging of the patients will affect the clinical effect of interferon therapy for hepatitis C.α-interferon should be actively applied after clearly and timely diagnosis of hepatitis C as soon as possible,which has important significance on the prognosis and clinical efficiency.
作者
秦峰
Qin Feng(The People's Hospital of Shizhu County,Chongqing City 409100)
出处
《中国社区医师》
2016年第32期33-34,共2页
Chinese Community Doctors
关键词
Α-干扰素
丙肝
临床效果
α-interferon
Hepatitis C
Clinical effect